| Year |
Citation |
Score |
| 2023 |
Singh H, Keller RB, Kapner KS, Dilly J, Raghavan S, Yuan C, Cohen EF, Tolstorukov M, Andrews E, Brais LK, da Silva A, Perez K, Rubinson DA, Surana R, Giannakis M, ... ... Wolpin BM, et al. Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37463056 DOI: 10.1158/1078-0432.CCR-22-3930 |
0.319 |
|
| 2022 |
Rubinson D, Wolpin BM, Warsofsky IS, Ryan DP, Perez K, Rahma O, Singh H, Yurgelun MB, Shapiro GI, Aguirre AJ, D'Andrea AD, Cleary JM. Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report. Journal of Gastrointestinal Oncology. 12: 3133-3140. PMID 35070436 DOI: 10.21037/jgo-21-197 |
0.351 |
|
| 2021 |
Biller LH, Wolpin BM, Goggins M. Inherited Pancreatic Cancer Syndromes and High-Risk Screening. Surgical Oncology Clinics of North America. 30: 773-786. PMID 34511196 DOI: 10.1016/j.soc.2021.06.002 |
0.337 |
|
| 2021 |
Chen H, Majumdar A, Wang L, Kar S, Brown KM, Feng H, Turman C, Dennis J, Easton D, Michailidou K, Simard J, Bishop T, Cheng IC, Huyghe JR, ... ... Wolpin BM, et al. Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. Hgg Advances. 2. PMID 34355204 DOI: 10.1016/j.xhgg.2021.100041 |
0.305 |
|
| 2021 |
Yuan C, Morales-Oyarvide V, Khalaf N, Perez K, Tabung FK, Ho GYF, Kooperberg C, Shadyab AH, Qi L, Kraft P, Sesso HD, Giovannucci EL, Manson JE, Stampfer MJ, Ng K, ... ... Wolpin BM, et al. Prediagnostic Inflammation and Pancreatic Cancer Survival. Journal of the National Cancer Institute. PMID 33739411 DOI: 10.1093/jnci/djab040 |
0.307 |
|
| 2020 |
Kim J, Yuan C, Babic A, Bao Y, Clish CB, Pollak MN, Amundadottir LT, Klein AP, Stolzenberg-Solomon RZ, Pandharipande PV, Brais LK, Welch MW, Ng K, Giovannucci EL, Sesso HD, ... ... Wolpin BM, et al. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32321713 DOI: 10.1158/1055-9965.Epi-19-1389 |
0.327 |
|
| 2019 |
Hamada T, Yuan C, Bao Y, Zhang M, Khalaf N, Babic A, Morales-Oyarvide V, Cochrane BB, Gaziano JM, Giovannucci EL, Kraft P, Manson JE, Ng K, Nowak JA, Rohan TE, ... ... Wolpin BM, et al. Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31427306 DOI: 10.1158/1055-9965.Epi-19-0577 |
0.317 |
|
| 2019 |
Hamada T, Yuan C, Yurgelun MB, Perez K, Khalaf N, Morales-Oyarvide V, Babic A, Nowak JA, Rubinson DA, Giannakis M, Ng K, Kraft P, Stampfer MJ, Giovannucci EL, Fuchs CS, ... ... Wolpin BM, et al. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. British Journal of Cancer. PMID 30867564 DOI: 10.1038/S41416-019-0426-5 |
0.311 |
|
| 2018 |
Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville T, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, ... ... Wolpin BM, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery. PMID 29853643 DOI: 10.1158/2159-8290.Cd-18-0349 |
0.316 |
|
| 2018 |
Hamada T, Khalaf N, Yuan C, Babic A, Morales-Oyarvide V, Qian ZR, Nowak JA, Ng K, Kraft P, Rubinson DA, Stampfer MJ, Giovannucci EL, Fuchs CS, Ogino S, Wolpin BM. Statin use and pancreatic cancer risk in two prospective cohort studies. Journal of Gastroenterology. PMID 29362938 DOI: 10.1007/S00535-018-1430-X |
0.325 |
|
| 2016 |
Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, et al. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas. 45: 1080-91. PMID 27518363 DOI: 10.1097/Mpa.0000000000000705 |
0.323 |
|
| 2016 |
Childs EJ, Chaffee KG, Gallinger S, Syngal S, Schwartz AG, Cote ML, Bondy ML, Hruban RH, Chanock SJ, Hoover RN, Fuchs CS, Rider DN, Amundadottir LT, Stolzenberg-Solomon R, Wolpin BM, et al. Association of common susceptibility variants of pancreatic cancer in higher risk patients: A PACGENE study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197284 DOI: 10.1158/1055-9965.Epi-15-1217 |
0.332 |
|
| 2016 |
Babic A, Wolpin BM. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker? Clinical Chemistry. 62: 307-9. PMID 26721295 DOI: 10.1373/Clinchem.2015.246538 |
0.314 |
|
| 2016 |
Wolpin BM. Pancreatic Cancer. Hematology/Oncology Clinics of North America. 29: xiii-xiv. PMID 26226911 DOI: 10.1016/j.hoc.2015.06.002 |
0.315 |
|
| 2014 |
Wu L, Goldstein AM, Yu K, Yang XR, Rabe KG, Arslan AA, Canzian F, Wolpin BM, Stolzenberg-Solomon R, Amundadottir LT, Petersen GM. Variants associated with susceptibility to pancreatic cancer and melanoma do not reciprocally affect risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1121-4. PMID 24642353 DOI: 10.1158/1055-9965.EPI-13-0627 |
0.329 |
|
| 2010 |
Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, ... ... Wolpin BM, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). International Journal of Cancer. Journal International Du Cancer. 127: 1421-8. PMID 20049842 DOI: 10.1002/Ijc.25148 |
0.305 |
|
| 2009 |
Wolpin BM, Stampfer MJ. Defining determinants of pancreatic cancer risk: are we making progress? Journal of the National Cancer Institute. 101: 972-3. PMID 19561317 DOI: 10.1093/jnci/djp182 |
0.308 |
|
| 2004 |
Jiang J, Paez JG, Lee JC, Bo R, Stone RM, DeAngelo DJ, Galinsky I, Wolpin BM, Jonasova A, Herman P, Fox EA, Boggon TJ, Eck MJ, Weisberg E, Griffin JD, et al. Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML. Blood. 104: 1855-8. PMID 15178581 DOI: 10.1182/Blood-2004-02-0712 |
0.339 |
|
| Show low-probability matches. |